License Agreements in the Pharmaceuticals Industry

1,168 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (2)
ACELRX PHARMACEUTICALS INC (2)
Acer Therapeutics Inc. (9)
Aclaris Therapeutics, Inc. (3)
ACURA PHARMACEUTICALS, INC (6)
Adamis Pharmaceuticals Corp (12)
ADIAL PHARMACEUTICALS, INC. (8)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (2)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (4)
ALIMERA SCIENCES INC (1)
ALSERES PHARMACEUTICALS INC (9)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (2)
ANGIOTECH PHARMACEUTICALS INC (8)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (1)
APRICUS BIOSCIENCES, INC. (8)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
Arog Pharmaceuticals, Inc. (3)
ARTELO BIOSCIENCES, INC. (10)
Artemis Therapeutics, Inc. (2)
ARVINAS, INC. (6)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (5)
Astex Pharmaceuticals, Inc (5)
ATAI Life Sciences B.V. (3)
Atea Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (17)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (2)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (9)
Bakhu Holdings, Corp. (5)
BARR PHARMACEUTICALS INC (2)
Baudax Bio, Inc. (6)
Bausch Health Companies Inc. (1)
BENTLEY PHARMACEUTICALS INC (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (3)
Biohaven Ltd. (2)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (5)
BRADLEY PHARMACEUTICALS INC (1)
Braeburn Pharmaceuticals, Inc. (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (1)
Cancer Prevention Pharmaceuticals, Inc. (4)
Cannabics Pharmaceuticals Inc. (3)
CANNAPOWDER, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
Cara Therapeutics, Inc. (7)
CASSAVA SCIENCES INC (5)
CELGENE CORP (1)
Cerecor Inc. (9)
Charlotte's Web Holdings, Inc. (7)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (11)
Clearside Biomedical, Inc. (12)
CNS Pharmaceuticals, Inc. (1)
Cocrystal Pharma, Inc. (6)
COLLEGIUM PHARMACEUTICAL, INC (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (2)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (4)
COSMO VENTURES INC (7)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (10)
CUMBERLAND PHARMACEUTICALS INC (2)
CymaBay Therapeutics, Inc. (4)
Dermata Therapeutics, Inc. (2)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (23)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (6)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (20)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (17)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (10)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (3)
Evofem Biosciences, Inc. (2)
Evolus, Inc. (5)
EYEGATE PHARMACEUTICALS INC (8)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (4)
EYETECH PHARMACEUTICALS INC (3)
Fulcrum Therapeutics, Inc. (2)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (4)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (8)
Horizon Pharma plc (21)
Hoth Therapeutics, Inc. (7)
IDENIX PHARMACEUTICALS INC (7)
Ikena Oncology, Inc. (2)
IMAGING3 INC (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
Innovive Pharmaceuticals, Inc. (3)
INSPIRE PHARMACEUTICALS INC (7)
IntelGenx Technologies Corp. (1)
Intra-Cellular Therapies, Inc. (4)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (8)
Jazz Pharmaceuticals plc (14)
Journey Medical Corp (3)
JUNIPER PHARMACEUTICALS INC (13)
Kala Pharmaceuticals, Inc. (5)
Kannalife Inc (2)
KING PHARMACEUTICALS INC (5)
KOS PHARMACEUTICALS INC (2)
Lannett Company, Inc. (3)
Level Brands, Inc. (5)
Lexaria Bioscience Corp. (15)
Lipocine Inc. (2)
Liquidia Corp (2)
Longboard Pharmaceuticals, Inc. (3)
Luckwel Pharmaceuticals Inc. (3)
Lumena Pharmaceuticals, Inc. (3)
MAP Pharmaceuticals, Inc. (4)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (3)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (2)
MJ Holdings, Inc. (2)
Molecular Insight Pharmaceuticals, Inc. (13)
MYnd Analytics, Inc. (1)
Nabriva Therapeutics plc (3)
NEKTAR THERAPEUTICS (4)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (3)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (2)
NovaBay Pharmaceuticals, Inc. (1)
Novan, Inc. (15)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (16)
OCULAR THERAPEUTIX, INC (4)
Odonate Therapeutics, Inc. (1)
OMEROS CORP (7)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (13)
Onconova Therapeutics, Inc. (3)
ONYX PHARMACEUTICALS INC (1)
OPIANT PHARMACEUTICALS, INC. (11)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (1)
Organon & Co. (1)
OSCIENT PHARMACEUTICALS CORP (8)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (1)
OTONOMY, INC. (2)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (19)
PaxMedica, Inc. (4)
PEAK PHARMACEUTICALS, INC. (1)
Petros Pharmaceuticals, Inc. (3)
Phathom Pharmaceuticals, Inc. (3)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (2)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (2)
PREDIX PHARMACEUTICALS HOLDINGS INC (2)
PRESTWICK PHARMACEUTICALS INC (2)
Processa Pharmaceuticals, Inc. (10)
ProPhase Labs, Inc. (2)
PROTEO INC (2)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (5)
QUARK PHARMACEUTICALS INC (14)
QUATRX PHARMACEUTICALS CO (6)
QUESTCOR PHARMACEUTICALS INC (1)
Quoin Pharmaceuticals, Ltd. (1)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (6)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (22)
Recro Pharma, Inc. (8)
Reliant Pharmaceuticals, Inc. (10)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (10)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (6)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (2)
SALIX PHARMACEUTICALS LTD (13)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (7)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (10)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
Somanta Pharmaceuticals Inc. (1)
Sonoma Pharmaceuticals, Inc. (8)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (4)
Supernus Pharmaceuticals, Inc. (8)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (5)
TAURIGA SCIENCES, INC. (4)
Terns Pharmaceuticals, Inc. (3)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (2)
Textmunication Holdings, Inc. (1)
TFF Pharmaceuticals, Inc. (3)
The Medicines Company (1)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (3)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (4)
Trevi Therapeutics, Inc. (4)
Tribute Pharmaceuticals Canada Inc. (3)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (5)
Urovant Sciences Ltd. (3)
Valera Pharmaceuticals Inc (4)
Vallon Pharmaceuticals, Inc. (1)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (6)
Virpax Pharmaceuticals, Inc. (6)
Vitality Biopharma, Inc. (3)
VIVUS INC (7)
Wave Life Sciences Ltd. (3)
WEED, INC. (1)
Zoetis (5)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (4)

Recent Contracts

License and Distribution Agreement, by and between the Company and Farma Mondo (certain provisions of this exhibit have been omitted pursuant to Regulation S-K, Item... (Quoin Pharmaceuticals, Ltd., Filed With SEC on September 13, 2023)
Exclusive License Agreement dated as of August 28, 2023 by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AB (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
Biological Materials License Agreement, dated August 26, 2019, by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute and... (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive License Agreement, dated August 5, 2019, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive License Agreement, dated November 11, 2020, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
Exclusive Patent License Agreement, dated as of June 18, 2020, by and between the U.S. Department of Health and Human Services, as represented by the National Institute of Allergy... (Baudax Bio, Inc., Filed With SEC on August 16, 2023)
License Agreement, dated as of April 28, 2023, by and between VYNE Therapeutics Inc. and Tay Therapeutics Limited (Menlo Therapeutics Inc., Filed With SEC on August 14, 2023)
License and Supply Agreement by and between Rani Therapeutics, LLC and Celltrion, Inc. dated May 26, 2023 (Rani Therapeutics Holdings, Inc., Filed With SEC on August 11, 2023)
License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Liquidia Corp, Filed With SEC on August 10, 2023)
License Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on August 9, 2023)
Amendment No. 10 to the License Agreement, dated May 22, 2023, by and among F. Hoffmann-La Roche Ltd, Hoffman-La Roche Inc. and Horizon Therapeutics Ireland DAC (as successor in... (Horizon Pharma plc, Filed With SEC on August 8, 2023)
License, Supply, and Distribution Agreement, dated as of May 9, 2023 by and between Symatese S.A.S. and the Registrant (Evolus, Inc., Filed With SEC on August 2, 2023)
Extension and Sixth Amending Agreement to Name and Likeness and License Agreement, effective as of June 30, 2023, by and between Leeland & Sig LLC d/b/a Stanley Brothers Brand... (Charlotte's Web Holdings, Inc., Filed With SEC on July 3, 2023)
Third Amendment to the Amended License, Development and Commercialization Agreement is made and entered into as of February 28, 2022 by the Registrant and between Abuse Deterrent... (ACURA PHARMACEUTICALS, INC, Filed With SEC on June 30, 2023)
Amendment #2 to the License, Development and Commercialization Agreement is made and entered into as of June 17, 2021 by the Registrant and between Abuse Deterrent Pharma, LLC (ACURA PHARMACEUTICALS, INC, Filed With SEC on June 30, 2023)
Amendment No. 1, dated April 20, 2023, to Amended and Restated Limited License Agreement between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Amended and Restated Limited License Agreement, dated June 27, 2022, between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Exclusive License Agreement, dated as of June 12, 2023, between Kiora Pharmaceuticals, Inc. and Sentrx Animal Care, Inc (EYEGATE PHARMACEUTICALS INC, Filed With SEC on June 15, 2023)
First Amendment to Intellectual Property License Agreement, dated as of June 12, 2023, between Kiora Pharmaceuticals, Inc. and Sentrx Animal Care, Inc (EYEGATE PHARMACEUTICALS INC, Filed With SEC on June 15, 2023)
Development and License Agreement, dated as of June 2, 2023, by and among the Company and Alvogen (Big Rock Partners Acquisition Corp., Filed With SEC on June 5, 2023)
Amendment to Development and License Agreement dated March 21 (Biohaven Ltd., Filed With SEC on May 12, 2023)
Development and License (Biohaven Ltd., Filed With SEC on May 12, 2023)
AnnJi License Agreement by and between the Company and AnnJi Pharmaceutical Co. Ltd., dated February 28, 2023 (AVENUE THERAPEUTICS, INC., Filed With SEC on May 12, 2023)
Patent and Technology License Agreement, dated May 14, 2014, between Novel Anti-Infective Technologies, LLC and Leonard-Meron Biosciences, Inc (Citius Pharmaceuticals, Inc., Filed With SEC on May 12, 2023)
License and Service Agreement dated February 8, 2007, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
First Addendum to the License and Service Agreement dated April 21, 2009, by and between Revance Therapeutics, Inc. and List Biological Laboratories, Inc (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
Second Letter Amendment to License Agreement dated (Revance Therapeutics, Inc., Filed With SEC on May 9, 2023)
Research License Agreement, dated as of March 31, 2023, by and between Liquidia Technologies, Inc. and Glaxo Group Limited (Liquidia Corp, Filed With SEC on May 8, 2023)
Exclusive License Agreement dated as of September 15, 2016, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
Amendment No. 1 to the License Agreement between TherapeuticsMD, Inc. and Mayne Pharma LLC, dated as of December 30, 2022 (TherapeuticsMD, Inc., Filed With SEC on April 7, 2023)
Exclusive License Agreement dated as of September 15, 2016, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
Exclusive License Agreement dated as of May 30, 2014, between National University of Singapore, Singapore Health Services Pte Ltd, the Registrant and 60P Australia Pty Ltd (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
License and Assignment Agreement, dated as of January 30, 2008, between the Company and ND Partners LLC (CorMedix Inc., Filed With SEC on March 30, 2023)
License Agreement, dated January 12, 2017, by and between Novan, Inc. and Sato Pharmaceutical Co. Ltd (Novan, Inc., Filed With SEC on March 30, 2023)
First Amendment, dated January 12, 2017 to the License Agreement, dated January 12, 2017, by and between Novan, Inc. and Sato Pharmaceutical Co. Ltd (Novan, Inc., Filed With SEC on March 30, 2023)
License Agreement, dated May 10, 2022, by and between Indus LF LLC and Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 29, 2023)
Brand License and Option Agreement, dated as of January 5, 2023 by and between JMS Brands LLC, and Charlottes Web, Inc (Charlotte's Web Holdings, Inc., Filed With SEC on March 23, 2023)
License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022 (Zomedica Pharmaceuticals Corp., Filed With SEC on March 15, 2023)